A 4-week, multicentre, randomized, double-blind, placebo controlled, double dummy, parallel group study, to assess the effect of lumiracoxib 100 mg o.d. and ibuprofen 600 mg t.i.d on 24-hour blood pressure profile and on urinary excretions of eicosanoids, in osteoarthritis patients with controlled hypertension

Trial Profile

A 4-week, multicentre, randomized, double-blind, placebo controlled, double dummy, parallel group study, to assess the effect of lumiracoxib 100 mg o.d. and ibuprofen 600 mg t.i.d on 24-hour blood pressure profile and on urinary excretions of eicosanoids, in osteoarthritis patients with controlled hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2007

At a glance

  • Drugs Ibuprofen; Lumiracoxib
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Nov 2007 Status change from recruiting to completed.
    • 07 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top